# OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
> **ANDA204233** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2017-04-24
## Drug
- **FDA Application Number:** ANDA204233
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2017-04-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204233)
---
*MORVS · CC0 1.0*